Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Has results × Lymphoma × Clear all

Phase

Status

Completed 363 Terminated 133 Active not recruiting 31 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1

Conditions

Lymphoma 1 Histiocytic Sarcoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Dendritic Cell Sarcoma, Follicular 1 Breast Neoplasms 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03316573 2026-02-10

Pembrolizumab in Neoplasms or Lymphomas

Dana-Farber Cancer Institute

Phase 2 Suspended

18 enrolled 16 charts

LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Dendritic Cell Sarcoma, Follicular, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡